Multidimensional circadian Monitoring by Wearable Biosensors in Parkinson’s Disease
Metadatos
Mostrar el registro completo del ítemAutor
Madrid Navarro, Carlos Javier; Escamilla-Sevilla, Francisco; Mínguez Castellanos, Adolfo; Campos, Manuel; Ruiz-Abellán, Fernando; Madrid, Juan A.; Rol, M. A.Editorial
Frontiers Media
Materia
Parkinson’s disease non-motor symptoms sleep
Fecha
2018-03-26Referencia bibliográfica
Madrid Navarro, C.J. et. al. Front. Neurol. 9:157. [https://doi.org/10.3389/fneur.2018.00157]
Patrocinador
Ministry of Economy and Competitiveness, the Instituto de Salud Carlos III through the CIBERFES (CB16/10/00239), grants 19899/GERM/15 and SAF2013- 49132-C2-1-R all of them awarded to JM (co-financed by FEDER)Resumen
Parkinson’s disease (PD) is associated with several non-motor symptoms that may
precede the diagnosis and constitute a major source of frailty in this population. The
digital era in health care has open up new prospects to move forward from the qualitative
and subjective scoring for PD with the use of new wearable biosensors that enable
frequent quantitative, reliable, repeatable, and multidimensional measurements to be
made with minimal discomfort and inconvenience for patients. A cross-sectional study
was conducted to test a wrist-worn device combined with machine-learning processing
to detect circadian rhythms of sleep, motor, and autonomic disruption, which can be
suitable for the objective and non-invasive evaluation of PD patients. Wrist skin temperature,
motor acceleration, time in movement, hand position, light exposure, and
sleep rhythms were continuously measured in 12 PD patients and 12 age-matched
healthy controls for seven consecutive days using an ambulatory circadian monitoring
device (ACM). Our study demonstrates that a multichannel ACM device collects reliable
and complementary information from motor (acceleration and time in movement) and
common non-motor (sleep and skin temperature rhythms) features frequently disrupted
in PD. Acceleration during the daytime (as indicative of motor impairment), time in movement
during sleep (representative of fragmented sleep) and their ratio (A/T) are the best
indexes to objectively characterize the most common symptoms of PD, allowing for a
reliable and easy scoring method to evaluate patients. Chronodisruption score, measured
by the integrative algorithm known as the circadian function index is directly linked
to a low A/T score. Our work attempts to implement innovative technologies based
on wearable, multisensor, objective, and easy-to-use devices, to quantify PD circadian
rhythms in huge populations over extended periods of time, while controlling at the same
time exposure to exogenous circadian synchronizers.